By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Accera, Inc. 

380 Interlocken Crescent
Suite 780
Broomfield  Colorado  80021  U.S.A.
Phone: 303-999-3700 Fax: 303-999-3799




Company News
Accera, Inc. Completes Enrollment Of Phase 3 NOURISH AD Study Of AC-1204 For The Treatment Of Alzheimer's Disease 5/12/2016 6:21:31 AM
Accera, Inc. To Present At BIO Asia International Conference 3/14/2016 8:39:34 AM
Accera, Inc. Appoints Ernest Wong, Ph.D., As Head Of Corporate Development 3/8/2016 6:22:49 AM
Accera, Inc. Joins Alzheimer's Association Research Roundtable 9/21/2015 10:57:48 AM
Accera, Inc. Supports World Alzheimer's Day 9/18/2015 6:06:55 AM
Accera, Inc. Reaches 75% Enrollment In The Phase 3 NOURISH AD Study Of AC-1204 For The Treatment Of Alzheimer's Disease 7/14/2015 6:37:17 AM
Accera, Inc. Appoints Charles Stacey, M.D., As President And CEO 6/2/2015 6:35:03 AM
Dr. Samuel Henderson, Accera, Inc.'s V.P. Of Research And Development, To Present At The 249th American Chemical Society National Meeting 2/20/2015 2:46:11 PM
Accera, Inc.To Moderate Symposium On Metabolic Dysregulation In Alzheimer's Disease During The 6th Annual Clinical Trials Conference On Alzheimer's Disease (CTAD) 11/11/2013 11:06:07 AM
Accera, Inc. Announces Publication of Results in the Journal Neuropsychiatric Disease and Treatment of a Retrospective Cohort Study Examining the Effects of Axona® in Patients With Mild-to-Moderate Alzheimer's Disease 10/29/2013 9:18:23 AM